JNJ
$177.18
Revenue | $23743Mn |
Net Profits | $5537Mn |
Net Profit Margins | 23.32% |
Johnson & Johnson’s revenue jumped 5.77% since last year same period to $23743Mn in the Q2 2025. On a quarterly growth basis, Johnson & Johnson has generated 8.45% jump in its revenue since last 3-months.
Johnson & Johnson’s net profit jumped 18.16% since last year same period to $5537Mn in the Q2 2025. On a quarterly growth basis, Johnson & Johnson has generated -49.66% fall in its net profits since last 3-months.
Johnson & Johnson’s net profit margin jumped 11.71% since last year same period to 23.32% in the Q2 2025. On a quarterly growth basis, Johnson & Johnson has generated -53.58% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.75 |
EPS Estimate Current Year | 2.75 |
Johnson & Johnson’s earning per share (EPS) estimates for the current quarter stand at 2.75 - a 2.61% jump from last quarter’s estimates.
Johnson & Johnson’s earning per share (EPS) estimates for the current year stand at 2.75.
Earning Per Share (EPS) | 2.77 |
Dividend Per Share (DPS) | 1.3 |
Johnson & Johnson’s earning per share (EPS) fell -1.77% since last year same period to 2.77 in the Q2 2025. This indicates that the Johnson & Johnson has generated -1.77% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Johnson & Johnson declared 1.3 dividend per share during the earnings announcement for Q2 2025.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-04-23 | 2.58 | 2.77 | 7.36% |
2025-07-24 | 2.68 | 2.77 | 3.36% |